Shearman & Sterling advised the underwriters in connection with the follow-on public offering by Inspire Medical Systems, Inc. of 2.3 million shares of common stock at a public offering price of $58.00 per share, resulting in aggregate gross proceeds to Inspire of approximately $133.4 million. The offering included 300,000 shares sold pursuant to the exercise in full of the option to purchase additional shares granted to the underwriters by Inspire in connection with the offering.

BofA Securities, J.P. Morgan and Goldman Sachs & Co. LLC acted as joint book-running managers for the offering and Guggenheim Securities and SVB Leerink acted as lead managers. 

 Inspire Medical Systems, Inc. is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. The company’s proprietary Inspire system is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

The Team